Egetis Therapeutics AB (publ) (STO:EGTX)
4.995
+0.245 (5.16%)
Mar 4, 2026, 5:29 PM CET
5.16% (1Y)
| Market Cap | 1.97B |
| Revenue (ttm) | 62.40M |
| Net Income (ttm) | -342.50M |
| Shares Out | 395.16M |
| EPS (ttm) | -0.93 |
| PE Ratio | n/a |
| Forward PE | 8.19 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 447,861 |
| Average Volume | 753,509 |
| Open | 4.765 |
| Previous Close | 4.750 |
| Day's Range | 4.705 - 4.995 |
| 52-Week Range | 3.025 - 7.070 |
| Beta | 1.13 |
| RSI | 47.43 |
| Earnings Date | Feb 26, 2026 |